Just a little bit of research would answer this one.
The revenue from the previous quarter was an up front licencing fee. The Royalties from product sales of that deal started this quarter.
So this result was expected as it is exactly as announced last Dec/Jan.
So this quarter will see another licencing fee, and royalities from that deal. There could also be Australian sales for insomnia and hope depending on launch date.
I hope this helps.
Ann: Appendix 4C - quarterly, page-5
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.077M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1457 | 71.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 5384 | 3 |
View Market Depth
| Last trade - 10.08am 16/08/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |
Day chart unavailable